LABCORP OFFERS EXPANDED PHARMACOGENOMIC SERVICES Read more about LABCORP OFFERS EXPANDED PHARMACOGENOMIC SERVICES
LABCORP TO PROVIDE CENTRALIZED LABORATORY SERVICES FOR CLINICAL TRIALS IN LATIN AMERICA Read more about LABCORP TO PROVIDE CENTRALIZED LABORATORY SERVICES FOR CLINICAL TRIALS IN LATIN AMERICA
LABORATORY CORPORATION OF AMERICA® ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE NATIONAL GENETICS INSTITUTE Read more about LABORATORY CORPORATION OF AMERICA® ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE NATIONAL GENETICS INSTITUTE
LABCORP COMPLETES ACQUISITION OF PATHOLOGY MEDICAL LABORATORIES IN CALIFORNIA Read more about LABCORP COMPLETES ACQUISITION OF PATHOLOGY MEDICAL LABORATORIES IN CALIFORNIA
LABORATORY CORPORATION OF AMERICA® SUCCESSFULLY COMPLETES PREFERRED STOCK REDEMPTION Read more about LABORATORY CORPORATION OF AMERICA® SUCCESSFULLY COMPLETES PREFERRED STOCK REDEMPTION
LABORATORY CORPORATION OF AMERICA® COMPLETES ACQUISITION OFNATIONAL GENETICS INSTITUTE Read more about LABORATORY CORPORATION OF AMERICA® COMPLETES ACQUISITION OFNATIONAL GENETICS INSTITUTE
Laboratory Corporation of America® Signs Group Purchasing Agreement with HealthTrust Purchasing Group, L.P. Read more about Laboratory Corporation of America® Signs Group Purchasing Agreement with HealthTrust Purchasing Group, L.P.
LabCorp® Presents HIV Study Suggesting Frequently Monitored Patients Show Better Suppression of HIV Viral Load Read more about LabCorp® Presents HIV Study Suggesting Frequently Monitored Patients Show Better Suppression of HIV Viral Load
LABCORP® FILES REGISTRATION STATEMENT TO ENABLE ROCHETO SELL UP TO 5.0 MILLION LABCORP® SHARES Read more about LABCORP® FILES REGISTRATION STATEMENT TO ENABLE ROCHETO SELL UP TO 5.0 MILLION LABCORP® SHARES
ROCHE HOLDINGS, INC. COMPLETES SALE OF 3.625 MILLION SHARES OF LABCORP® COMMON STOCK Read more about ROCHE HOLDINGS, INC. COMPLETES SALE OF 3.625 MILLION SHARES OF LABCORP® COMMON STOCK
